General Information of Drug (ID: DMVXW4L)

Drug Name
MYRIOCIN Drug Info
Synonyms
Myriocin; thermozymocidin; 35891-70-4; ISP-I; ISP-1; UNII-YRM4E8R9ST; (2S,3R,4R,6E)-2-Amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxo-6-eicosenoic acid; YRM4E8R9ST; Myriocin, Mycelia sterilia; Myriocin from Mycelia sterilia; CHEBI:582124; NCGC00163597-02; NCGC00163597-03; DSSTox_CID_26360; DSSTox_RID_81561; (2S,3R,4R,6E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid; DSSTox_GSID_46360; [2S,3R,4R]-(E)-2-Amino-3,4-dihydroxy-2-[hydroxymethyl]-14-oxo-6-eicosenoic Acid
Cross-matching ID
PubChem CID
6438394
ChEBI ID
CHEMBL55076
CAS Number
CAS 35891-70-4
TTD Drug ID
D07MQF

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Spliceosome 2.41 0.00e+0 101/150 (67.33%) HSPA1A;SNRPG;SNRPB2;...
Ribosome biogenesis in eukaryotes 2.27 0.00e+0 52/108 (48.15%) POP4;NXT1;MPHOSPH10;...
Base excision repair 2.05 1.55e-3 29/33 (87.88%) PCNA;POLE2;PARP2;...
DNA replication 1.99 2.32e-3 34/36 (94.44%) PCNA;POLE2;FEN1;...
Proteasome 1.87 1.02e-2 44/46 (95.65%) ADRM1;PSME4;PSMD6;...
Fanconi anemia pathway 1.87 8.52e-3 36/54 (66.67%) HES1;FANCL;CENPX;...
Cell cycle 1.86 7.30e-3 110/124 (88.71%) CDC20;PCNA;SMAD3;...
Arginine biosynthesis -1.66 2.94e-2 17/22 (77.27%) GOT2;CPS1;GPT;...
Cysteine and methionine metabolism -1.66 3.03e-2 43/50 (86%) KYAT1;SDS;BHMT;...
Pentose phosphate pathway -1.66 3.12e-2 25/30 (83.33%) PFKL;RPE;RGN;...
Epithelial cell signaling in Helicobacter pylori infect... -1.67 2.97e-2 62/70 (88.57%) JAM2;PLCG1;ATP6V0E2;...
Autophagy -1.68 2.92e-2 113/169 (66.86%) PRKAA1;PIK3CA;TSC1;...
HIF-1 signaling pathway -1.68 3.03e-2 105/109 (96.33%) PFKL;EP300;AKT2;...
Histidine metabolism -1.68 3.04e-2 16/22 (72.73%) ASPA;MAOA;ALDH3B1;...
Proximal tubule bicarbonate reclamation -1.69 2.94e-2 21/23 (91.3%) FXYD2;ATP1A1;GLUD2;...
Leukocyte transendothelial migration -1.70 2.66e-2 90/114 (78.95%) PRKCB;PLCG1;ARHGAP35;...
Biosynthesis of unsaturated fatty acids -1.70 2.71e-2 21/27 (77.78%) ELOVL4;ACAA1;HSD17B4;...
Thyroid cancer -1.71 2.65e-2 36/37 (97.3%) TCF7L2;NTRK1;TCF7;...
Sphingolipid signaling pathway -1.71 2.77e-2 106/119 (89.08%) SGPP1;PLCB2;AKT2;...
Collecting duct acid secretion -1.71 2.91e-2 22/27 (81.48%) ATP6V0E2;ATP4B;CLCNKB;...
Thyroid hormone synthesis -1.72 2.70e-2 66/75 (88%) ITPR1;FXYD2;PLCB3;...
Galactose metabolism -1.73 2.54e-2 26/31 (83.87%) GAA;PFKP;PFKM;...
Ferroptosis -1.73 2.69e-2 36/41 (87.8%) ACSL1;ACSL3;TFRC;...
Rheumatoid arthritis -1.74 2.69e-2 78/93 (83.87%) ATP6V0E1;ATP6V1F;FLT1;...
Neutrophil extracellular trap formation -1.74 2.87e-2 101/189 (53.44%) PRKCB;PLCG1;AQP9;...
Phagosome -1.76 2.58e-2 118/152 (77.63%) TAP2;ATP6V0E2;RAB5B;...
Glyoxylate and dicarboxylate metabolism -1.78 2.67e-2 23/30 (76.67%) HAO2;GLDC;CS;...
Central carbon metabolism in cancer -1.78 2.54e-2 67/70 (95.71%) PFKL;PDGFRB;AKT2;...
Viral myocarditis -1.79 2.40e-2 53/60 (88.33%) HLA-DOA;HLA-DQB1;HLA-F;...
Bladder cancer -1.80 2.50e-2 40/41 (97.56%) SRC;DAPK1;MAPK1;...
Glycine, serine and threonine metabolism -1.81 2.77e-2 31/40 (77.5%) CBS;GATM;PSPH;...
Folate biosynthesis -1.81 3.12e-2 23/26 (88.46%) ALPL;GCH1;PAH;...
Protein processing in endoplasmic reticulum -1.81 2.97e-2 127/171 (74.27%) AMFR;DAD1;DERL1;...
Glycolysis / Gluconeogenesis -1.91 1.39e-2 56/67 (83.58%) PKM;ALDOC;PFKP;...
Pyruvate metabolism -1.98 0.00e+0 41/47 (87.23%) HAGH;MDH2;ACAT1;...
Lysosome -1.99 0.00e+0 115/128 (89.84%) CTSW;AP3S2;DNASE2;...
Valine, leucine and isoleucine degradation -2.03 0.00e+0 42/48 (87.5%) BCAT2;AUH;ACAA1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-673 CVCL_0080 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.04uM - 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CL-34 CVCL_1123 Homo sapiens 10uM 6H
HT-29 CVCL_0320 Homo sapiens 0.04uM - 10uM 6H, 24H
LoVo CVCL_0399 Homo sapiens 10uM 6H
MDST8 CVCL_1400 Homo sapiens 10uM 6H
NCI-H508 CVCL_1561 Homo sapiens 10uM 6H
SNU-1040 CVCL_5001 Homo sapiens 10uM 6H
SNU-C4 CVCL_5008 Homo sapiens 10uM 6H
SNU-C5 CVCL_5009 Homo sapiens 10uM 6H
SW480 CVCL_0546 Homo sapiens 10uM 6H
SW620 CVCL_0547 Homo sapiens 10uM 6H
SW948 CVCL_0550 Homo sapiens 10uM 6H
Colorectal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCT 116 CVCL_0291 Homo sapiens 10uM 6H
HT115 CVCL_1294 Homo sapiens 10uM 6H
RKO CVCL_0504 Homo sapiens 10uM 6H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 10uM 6H
SNG-M CVCL_1707 Homo sapiens 10uM 6H
Endometrial carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHUEM-2 CVCL_1327 Homo sapiens 10uM 6H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.04uM - 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 0.04uM - 10uM 6H, 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.04uM - 10uM 6H, 24H
DV-90 CVCL_1184 Homo sapiens 10uM 6H
SK-LU-1 CVCL_0624 Homo sapiens 10uM 6H
Lung adenosquamous carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H596 CVCL_1571 Homo sapiens 10uM 6H
Lung large cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
COR-L23 CVCL_1133 Homo sapiens 10uM 6H
T3M-10 CVCL_1729 Homo sapiens 10uM 6H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC15 CVCL_1253 Homo sapiens 10uM 6H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1299 CVCL_0060 Homo sapiens 10uM 6H
HCC515 CVCL_5134 Homo sapiens 0.04uM - 10uM 6H, 24H
NCI-H2073 CVCL_1523 Homo sapiens 10uM 6H
Small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1694 CVCL_1495 Homo sapiens 10uM 6H
NCI-H1836 CVCL_1502 Homo sapiens 10uM 6H
Lymph node
Diffuse large B-cell lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
WSU-DLCL2 CVCL_1787 Homo sapiens 10uM 6H
Ovary
Ovarian carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
EFO-27 CVCL_1194 Homo sapiens 10uM 6H
OV7 CVCL_1623 Homo sapiens 10uM 6H
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
RMG-I CVCL_1663 Homo sapiens 10uM 6H
Ovarian mucinous cystadenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
COV644 CVCL_2011 Homo sapiens 10uM 6H
RMUG-S CVCL_1666 Homo sapiens 10uM 6H
Ovarian undifferentiated carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
TYK-nu CVCL_1774 Homo sapiens 10uM 6H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 10uM 6H
Acute myeloid leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NOMO-1 CVCL_1609 Homo sapiens 10uM 6H
PL-21 CVCL_2161 Homo sapiens 10uM 6H
SKM-1 CVCL_0010 Homo sapiens 10uM 6H
Pleural effusion
Histiocytic lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-937 CVCL_0007 Homo sapiens 10uM 6H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.04uM - 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.04uM - 10uM 6H, 24H
SK-MEL-1 CVCL_0523 Homo sapiens 10uM 6H
SK-MEL-28 CVCL_0526 Homo sapiens 10uM 6H
Stomach
Gastric adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
AGS CVCL_0139 Homo sapiens 10uM 6H